<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>医学新闻</title><description>来自 News-Medical.Net - 来自世界各地的最新医学新闻和研究</description><link/>https://www.news-medical.net/<language> en-GB</language><item><title>钠尿引导利尿治疗可改善急性心力衰竭的充血缓解</title><description>根据今天在 ESC 2023 年大会热线会议上提出的最新突破性研究，急性心力衰竭患者的实用尿钠引导利尿方法可显着增加 24 小时尿钠排泄，而不影响全因死亡率或心力衰竭再住院率。</description><link/> https://www.news-medical.net/news/20230829/Natriuresis-guided-diuretic-therapy-improves-decongestion-in-acute-heart-failure.aspx<comments> https://www.news-medical.net/news/20230829/Natriuresis-guided-diuretic-therapy-improves-decongestion-in-acute-heart-failure.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=b2fa2608-0582-4e01-9333-b24a03005da9</guid><pubDate> Tue, 29 Aug 2023 15:36:59 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/1/Anatomy_of_Human_Heart.-Liya_Graphics_5ac9d64765b747899bc4a9ef77468432-620x480.jpg" width="620"><media:description><![CDATA[Natriuresis-guided diuretic therapy improves decongestion in acute heart failure]]></media:description></media:content></item><item><title>独家：倡导者称 CMS 研究破坏了加强疗养院人员配置的努力</title><description>拜登政府去年承诺为全国约 15,000 家疗养院制定最低人员配置水平。这是改革该行业议程的核心，政府称该行业充斥着不合格的护理和不遵守联邦质量规则的现象。</description><link/> https://www.news-medical.net/news/20230829/Exclusive-CMS-study-sabotages-efforts-to-bolster-nursing-home-staffing-advocates-say.aspx<comments> https://www.news-medical.net/news/20230829/Exclusive-CMS-study-sabotages-efforts-to-bolster-nursing-home-staffing-advocates-say.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=5c38252b-7a3f-4171-a84c-3bee651da8d6</guid><pubDate> Tue, 29 Aug 2023 15:35:18 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Nursing-620x480.jpg" width="620"><media:description><![CDATA[Exclusive: CMS study sabotages efforts to bolster nursing home staffing, advocates say]]></media:description></media:content></item><item><title> ARAMIS 试验发现阿那白滞素对急性心肌炎没有益处</title><description>对急性心肌炎患者进行的最大规模的随机对照试验发现，阿那白滞素是安全的，但并不能减少并发症。今天在 2023 年 ESC 大会的热线会议上介绍了这项最新的突破性研究。</description><link/> https://www.news-medical.net/news/20230829/ARAMIS-trial-finds-no-benefit-of-anakinra-in-acute-myocarditis.aspx<comments> https://www.news-medical.net/news/20230829/ARAMIS-trial-finds-no-benefit-of-anakinra-in-acute-myocarditis.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=dc5b2edd-ab29-4d13-9858-18af21208185</guid><pubDate> Tue, 29 Aug 2023 15:28:12 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/heart-620x480.jpg" width="620"><media:description><![CDATA[ARAMIS trial finds no benefit of anakinra in acute myocarditis]]></media:description></media:content></item><item><title>延长 P2Y12 抑制剂单药治疗可减少 ACS 患者的出血和缺血事件</title><description>经皮冠状动脉介入治疗 (PCI) 后延长 P2Y12 抑制剂单药治疗超过 12 个月可减少急性冠脉综合征 (ACS) 患者的出血和缺血事件，这些患者具有两种类型事件的高风险。</description><link/> https://www.news-medical.net/news/20230829/Extended-P2Y12-inhibitor-monotherapy-reduces-bleeding-and-ischemic-events-in-ACS-患者.aspx<comments> https://www.news-medical.net/news/20230829/Extended-P2Y12-inhibitor-monotherapy-reduces-bleeding-and-ischemic-events-in-ACS-患者.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=17d98166-192b-4c47-b411-eca9a70d97af</guid><pubDate> Tue, 29 Aug 2023 15:22:26 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/1/Heart_-_CLIPAREA_l_Custom_media_2e30afb66e13426eb5cd994ac2980fd7-620x480.jpg" width="620"><media:description><![CDATA[Extended P2Y12 inhibitor monotherapy reduces bleeding and ischemic events in ACS patients]]></media:description></media:content></item><item><title>初次 PCI 后的抗凝治疗并不能预防 STEMI 患者的不良后果</title><description>根据今日 ESC 2023 年大会热线会议上公布的最新突破性研究，初次经皮冠状动脉介入治疗 (PCI) 后的抗凝治疗并不能预防 ST 段抬高型心肌梗死 (STEMI) 患者的不良后果。</description><link/> https://www.news-medical.net/news/20230829/Anticoagulation-after-primary-PCI-does-not-prevent-adverse-outcomes-in-STEMI-患者.aspx<comments> https://www.news-medical.net/news/20230829/Anticoagulation-after-primary-PCI-does-not-prevent-adverse-outcomes-in-STEMI-患者.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=ddc85f6a-54f8-4314-adf6-95a142645a82</guid><pubDate> Tue, 29 Aug 2023 15:04:28 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2015/3/Diabetes_Mellitus1_4a874c8237104d59ac7810769f8e78a2-620x480.jpg" width="620"><media:description><![CDATA[Anticoagulation after primary PCI does not prevent adverse outcomes in STEMI patients]]></media:description></media:content></item><item><title>急性失代偿性心力衰竭早期开始使用达格列净并不能提高利尿效率</title><description>根据 2017 年发表的最新研究，与结构化常规护理相比，早期开始使用钠葡萄糖协同转运蛋白 2 (SGLT2) 抑制剂达格列净并未导致住院急性失代偿性心力衰竭 (ADHF) 患者的利尿效率有统计学上的显着改善。今天在 2023 年 ESC 大会上举行热线会议。</description><link/> https://www.news-medical.net/news/20230829/Early-initiation-of-dapagliflozin-in-acute-decompensated-heart-failure-does-not-improve-diuretic-efficiency.aspx<comments> https://www.news-medical.net/news/20230829/Early-initiation-of-dapagliflozin-in-acute-decompensated-heart-failure-does-not-improve-diuretic-efficiency.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=55b2496a-5a9b-43cf-bcbb-d6cdc80d514f</guid><pubDate> Tue, 29 Aug 2023 14:54:25 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/4/Anatomically_correct_3d_model_of_human_heart-u3d_2cbbdab779c84457877be90c0f055b76-620x480.jpg" width="620"><media:description><![CDATA[Early initiation of dapagliflozin in acute decompensated heart failure does not improve diuretic efficiency]]></media:description></media:content></item><item><title>试验发现，对于窦房结功能障碍患者，最小化心房起搏没有任何益处</title><description>今天在 ESC 2023 年大会热线会议上发表的最新研究表明，最小化心房起搏并不能预防窦房结功能障碍患者的房颤。</description><link/> https://www.news-medical.net/news/20230829/Trial-finds-no-benefit-of-minimizing-atrial-pacing-in-病人-with-sinus-node-dysfunction.aspx<comments> https://www.news-medical.net/news/20230829/Trial-finds-no-benefit-of-minimizing-atrial-pacing-in-病人-with-sinus-node-dysfunction.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=20360c28-a821-4ada-8c5a-00a0df4a9d43</guid><pubDate> Tue, 29 Aug 2023 14:46:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Pacemaker-620x480.jpg" width="620"><media:description><![CDATA[Trial finds no benefit of minimizing atrial pacing in patients with sinus node dysfunction]]></media:description></media:content></item><item><title> SGLT2 抑制剂不会降低住院 COVID-19 患者的 28 天死亡率</title><description>根据今天热线会议上公布的最新研究，与常规治疗或安慰剂相比，钠葡萄糖协同转运蛋白 2 (SGLT2) 抑制剂不会降低住院 COVID-19 患者的 28 天全因死亡率2023 年 ESC 大会。</description><link/> https://www.news-medical.net/news/20230829/SGLT2-inhibitors-do-not-reduce-28-day-mortality-in-hospitalized-COVID-19-病人.aspx<comments> https://www.news-medical.net/news/20230829/SGLT2-inhibitors-do-not-reduce-28-day-mortality-in-hospitalized-COVID-19-病人.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=71781fa1-0677-4a4b-a611-2aa3bb17cbb4</guid><pubDate> Tue, 29 Aug 2023 14:39:56 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Thrombosis-620x480.jpg" width="620"><media:description><![CDATA[SGLT2 inhibitors do not reduce 28-day mortality in hospitalized COVID-19 patients]]></media:description></media:content></item><item><title>无机硝酸盐可减少高危患者造影剂诱发的肾病</title><description>根据今天在 ESC 热线会议上发表的最新突破性研究，与安慰剂相比，对于因急性冠脉综合征而接受冠状动脉造影的肾损伤风险患者，无机硝酸盐可减少造影剂肾病 (CIN)、改善肾脏结局并减少心脏事件2023 年国会。</description><link/> https://www.news-medical.net/news/20230829/Inorganic-硝酸盐-reduces-contrast-induced-nephropathy-in-high-risk-病人.aspx<comments> https://www.news-medical.net/news/20230829/Inorganic-硝酸盐-reduces-contrast-induced-nephropathy-in-high-risk-病人.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=b43bbdac-0346-491e-ac61-d23bbcb001ed</guid><pubDate> Tue, 29 Aug 2023 13:58:10 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2018/7/Coronary_angiography_%2c_left_coronary_angiography%2c_stenosis_at_proximal_Left_Ante_-_Pitchyfoto_A1_7c158570dca1414c9f3bfda1e773654a-620x480.jpg" width="620"><media:description><![CDATA[Inorganic nitrate reduces contrast-induced nephropathy in high-risk patients]]></media:description></media:content></item><item><title>较长时间的抗凝治疗有利于患有孤立性远端 DVT 的癌症患者</title><description>根据今日 ESC 2023 年大会热线会议上公布的最新突破性研究，在减少癌症和远端深静脉血栓 (DVT) 患者的血栓事件方面，12 个月的艾多沙班优于三个月。</description><link/> https://www.news-medical.net/news/20230829/Longer-duration-of-anticoagulation-therapy-benefits-cancer-患者-with-isolated-distal-DVT.aspx<comments> https://www.news-medical.net/news/20230829/Longer-duration-of-anticoagulation-therapy-benefits-cancer-患者-with-isolated-distal-DVT.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=71428435-a791-4945-a457-9375a1c7004a</guid><pubDate> Tue, 29 Aug 2023 13:42:18 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/174318220-620x480.jpg" width="620"><media:description><![CDATA[Longer duration of anticoagulation therapy benefits cancer patients with isolated distal DVT]]></media:description></media:content></item></channel></rss>